Capricor Therapeutics | CAPR - Current Liabilities


Capricor Therapeutics reported $35.84M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Geron USD 113.82M 26.11M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 30.08M 2.77M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Prothena USD 40.84M 10.59M Dec/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025